Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity

被引:18
作者
Dhanda, Sandeep Kumar [1 ]
Grifoni, Alba [1 ]
Pham, John [1 ]
Vaughan, Kerrie [1 ]
Sidney, John [1 ]
Peters, Bjoern [1 ]
Sette, Alessandro [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA
关键词
antigen; peptides; epitopes; bioinformatics; MHC; HLA; regulation; suppression; T cell; T-CELL EPITOPES; FACTOR VIIA ANALOG; RECOMBINANT IMMUNOTOXIN; THERAPEUTIC PROTEINS; ANALYSIS RESOURCE; RATIONAL DESIGN; MOUSE MODEL; IN-VITRO; DEIMMUNIZATION; IDENTIFICATION;
D O I
10.1111/imm.12816
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Unwanted immune responses against protein therapeutics can reduce efficacy or lead to adverse reactions. T-cell responses are key in the development of such responses, and are directed against immunodominant regions within the protein sequence, often associated with binding to several allelic variants of HLA class II molecules (promiscuous binders). Herein, we report a novel computational strategy to predict de-immunized' peptides, based on previous studies of erythropoietin protein immunogenicity. This algorithm (or method) first predicts promiscuous binding regions within the target protein sequence and then identifies residue substitutions predicted to reduce HLA binding. Further, this method anticipates the effect of any given substitution on flanking peptides, thereby circumventing the creation of nascent HLA-binding regions. As a proof-of-principle, the algorithm was applied to Vatreptacog , an engineered Factor VII molecule associated with unintended immunogenicity. The algorithm correctly predicted the two immunogenic peptides containing the engineered residues. As a further validation, we selected and evaluated the immunogenicity of seven substitutions predicted to simultaneously reduce HLA binding for both peptides, five control substitutions with no predicted reduction in HLA-binding capacity, and additional flanking region controls. In vitro immunogenicity was detected in 214% of the cultures of peptides predicted to have reduced HLA binding and 114% of the flanking regions, compared with 46% for the cultures of the peptides predicted to be immunogenic. This method has been implemented as an interactive application, freely available online at .
引用
收藏
页码:118 / 132
页数:15
相关论文
共 72 条
  • [51] Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals
    Schulten, Veronique
    Greenbaum, Jason A.
    Hauser, Michael
    McKinney, Denise M.
    Sidney, John
    Kolla, Ravi
    Arlehamn, Cecilia S. Lindestam
    Oseroff, Carla
    Alam, Rapheul
    Broide, David H.
    Ferreira-Briza, Fatima
    Grey, Howard M.
    Sette, Alessandro
    Peters, Bjoern
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (09) : 3459 - 3464
  • [52] SETTE A, 1994, J IMMUNOL, V153, P5586
  • [53] Divergent Motifs but Overlapping Binding Repertoires of Six HLA-DQ Molecules Frequently Expressed in the Worldwide Human Population
    Sidney, John
    Steen, Amiyah
    Moore, Carrie
    Ngo, Sandy
    Chung, Jolan
    Peters, Bjoern
    Sette, Alessandro
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (07) : 4189 - 4198
  • [54] Five HLA-DP Molecules Frequently Expressed in the Worldwide Human Population Share a Common HLA Supertypic Binding Specificity
    Sidney, John
    Steen, Amiyah
    Moore, Carrie
    Ngo, Sandy
    Chung, Jolan
    Peters, Bjoern
    Sette, Alessandro
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 184 (05) : 2492 - 2503
  • [55] ROCR: visualizing classifier performance in R
    Sing, T
    Sander, O
    Beerenwinkel, N
    Lengauer, T
    [J]. BIOINFORMATICS, 2005, 21 (20) : 3940 - 3941
  • [56] SNOKE K, 1993, J IMMUNOL, V151, P6815
  • [57] Southwood S, 1998, J IMMUNOL, V160, P3363
  • [58] CRYSTAL-STRUCTURE OF THE HUMAN CLASS-II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA-VIRUS PEPTIDE
    STERN, LJ
    BROWN, JH
    JARDETZKY, TS
    GORGA, JC
    URBAN, RG
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1994, 368 (6468) : 215 - 221
  • [59] Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity
    Stish, B. J.
    Oh, S.
    Chen, H.
    Dudek, A. Z.
    Kratzke, R. A.
    Vallera, D. A.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (07) : 1114 - 1123
  • [60] Rationally engineered therapeutic proteins with reduced immunogenicity
    Tangri, S
    Mothé, BR
    Eisenbraun, J
    Sidney, J
    Southwood, S
    Briggs, K
    Zinckgraf, J
    Bilsel, P
    Newman, M
    Chesnut, R
    LiCalsi, C
    Sette, A
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (06) : 3187 - 3196